Spirocycle integrin inhibitors
CA 2249733 A1 · Owner: Jadhav, Prabhakar Kondaji · Inventors: Jadhav, Prabhakar Kondaji; Smallheer, Joanne Marie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to novel heterocycles including (S)-2-, phenylsulfonylamino-3-8-(2-pyridinylaminomethyl)--1-oxa-2-azaspiro-4,5dec-2-en-3-ylcarbonylaminopropionic acid which are useful as antagonists of , the .alpha.v.beta.3 integrin and related cell surface adhesive protein receptors, to pharmaceutical compositions containing such compounds processes , for preparing such compounds and to methods of using these compounds alone , or in combination with other therapeutic agents for the inhibition of cell , adhesion, the treatment of angiogenic disorders inflammation, bone , degradation, cancer metastasis diabetic retinopathy, thrombosis, restenosis macular degeneration, and other …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 17, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 17, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.